113 related articles for article (PubMed ID: 35299116)
1. From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series.
Meden A; Knez D; Brazzolotto X; Nachon F; Dias J; Svete J; Stojan J; Grošelj U; Gobec S
Eur J Med Chem; 2022 Apr; 234():114248. PubMed ID: 35299116
[TBL] [Abstract][Full Text] [Related]
2. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
3. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
4. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
5. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.
Meden A; Knez D; Jukič M; Brazzolotto X; Gršič M; Pišlar A; Zahirović A; Kos J; Nachon F; Svete J; Gobec S; Grošelj U
Chem Commun (Camb); 2019 Mar; 55(26):3765-3768. PubMed ID: 30864579
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-irreversible butyrylcholinesterase inhibitors: Structure-activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead.
Meden A; Knez D; Brazzolotto X; Modeste F; Perdih A; Pišlar A; Zorman M; Zorović M; Denic M; Pajk S; Živin M; Nachon F; Gobec S
Eur J Med Chem; 2023 Feb; 247():115048. PubMed ID: 36586299
[TBL] [Abstract][Full Text] [Related]
8. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.
Takao K; Toda K; Saito T; Sugita Y
Chem Pharm Bull (Tokyo); 2017; 65(11):1020-1027. PubMed ID: 29093288
[TBL] [Abstract][Full Text] [Related]
10. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
11. Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group.
Liu H; Liu L; Gao X; Liu Y; Xu W; He W; Jiang H; Tang J; Fan H; Xia X
Eur J Med Chem; 2017 Jan; 126():810-822. PubMed ID: 27951489
[TBL] [Abstract][Full Text] [Related]
12. The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
Košak U; Brus B; Knez D; Žakelj S; Trontelj J; Pišlar A; Šink R; Jukič M; Živin M; Podkowa A; Nachon F; Brazzolotto X; Stojan J; Kos J; Coquelle N; Sałat K; Colletier JP; Gobec S
J Med Chem; 2018 Jan; 61(1):119-139. PubMed ID: 29227101
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
Gonzalez J; Ramirez J; Schwans JP
Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors.
Meden A; Knez D; Malikowska-Racia N; Brazzolotto X; Nachon F; Svete J; Sałat K; Grošelj U; Gobec S
Eur J Med Chem; 2020 Dec; 208():112766. PubMed ID: 32919297
[TBL] [Abstract][Full Text] [Related]
18. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
19. Multivalent butyrylcholinesterase inhibitor discovered by exploiting dynamic combinatorial chemistry.
Zhao S; Xu J; Zhang S; Han M; Wu Y; Li Y; Hu L
Bioorg Chem; 2021 Mar; 108():104656. PubMed ID: 33548731
[TBL] [Abstract][Full Text] [Related]
20. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
Kumar RS; Almansour AI; Arumugam N; Al-Thamili DM; Basiri A; Kotresha D; Manohar TS; Venketesh S; Asad M; Asiri AM
Bioorg Chem; 2018 Dec; 81():134-143. PubMed ID: 30121001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
